Invivyd (IVVD) announced the appointment of Kristie Kuhl as Chief Communications Officer. Kuhl will lead the Company’s communications and patient advocacy efforts as Invivyd advances its mission of providing monoclonal antibodies for the prevention and treatment of viral disease. Kuhl most recently served as Global Managing Director, Health & Wellness at Zeno Group
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IVVD:
- Invivyd’s Strategic Growth and Diversification: Analyst Recommends Buy Rating
- Invivyd announces SPEAR Study Group recommended Long COVID study design
- Invivyd’s Promising Position in the Antibody Market: Buy Rating Supported by Strong Data and Financial Growth
- Invivyd Raises $53.5 Million in Public Offering
- Invivyd 50M share Spot Secondary priced at 52c